Merck & Co., Inc: Cystic Fibrosis trials
The registry lists 10 Cystic Fibrosis studies with Merck & Co., Inc as lead sponsor. 0 are open to participants now and 1 have results posted.
Phase 1 1Phase 2 7Phase 3 3(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- A Study of RPL554 in Patients With Cystic FibrosisCompletedNCT02919995Phase 2Results posted
- A Safety and Tolerability Study of Denufosol in 2-4 Year OldsCompletedNCT01181622Phase 2
- Study 08-114 Open-label Extension of Study 08-110 - A Multi-Center Study of Denufosol Tetrasodium Inhalation Solution in Patients With Cystic Fibrosis Lung Disease (P08642)TerminatedNCT00846781Phase 3
- Study of Denufosol Tetrasodium Inhalation Solution in Patients With Cystic Fibrosis (CF) Lung DiseaseCompletedNCT00625612Phase 3
- Study of Denufosol Inhalation Solution in Patients With Mild to Moderate Cystic Fibrosis Lung DiseaseTerminatedNCT00425165Phase 2
- Study of Denufosol Inhalation Solution in Patients With Mild Cystic Fibrosis Lung DiseaseCompletedNCT00357279Phase 3
- A Study in Pediatric Patients With Cystic Fibrosis Lung DiseaseCompletedNCT00130182Phase 2
- Study of Denufosol Tetrasodium in Patients With Cystic Fibrosis Lung DiseaseCompletedNCT00103714Phase 2
- Study of INS37217 Inhalation Solution in Mild to Moderate Cystic Fibrosis Lung DiseaseCompletedNCT00056147Phase 2
- A Study in Adult and Pediatric Patients With Cystic FibrosisCompletedNCT00034515Phase 1/2